Ono Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
urelumab (BMS-663513) / BMS, Ono Pharma           
          
            
             
lirilumab (BMS-986015) / Innate, BMS, Ono Pharma           
          
            
             
cabiralizumab (BMS-986227) / Ono Pharma, BMS           
          
            
             
Velexbru (tirabrutinib) / Ono Pharma, Gilead           
          
            
             
BMS-986207 / BMS           
          
            
             
eltanexor (KPT-8602) / Ono Pharma, Karyopharm           
          
            
             
Cereact (arundic acid) / Ono Pharma           
          
            
             
ONO-2952 / Ono Pharma           
          
            
             
ONO-4053 / Ono Pharma           
          
            
             
atamparib (RBN-2397) / Ribon Therap           
          
            
             
gemilukast (ONO-6950) / Ono Pharma           
          
            
             
BMS-986310 / BMS, Ono Pharma           
          
            
             
ONO-8539 / Ono Pharma           
          
            
             
eribulin liposomal (E7389-LF) / Eisai, Ono Pharma           
          
            
             
ipilimumab subcutaneous (BMS-734016 SC) / Ono Pharma, BMS           
          
            
             
ONO-2808 / Ono Pharma           
          
            
             
ONO-4474 / Ono Pharma           
          
            
             
ONO-7579 / Ono Pharma           
          
            
             
tamnorzatinib (ONO-7475) / Ono Pharma           
          
            
             
Joyclu (diclofenac etalhyaluronate) / Seikagaku, Ono Pharma, Eisai           
          
            
             
ONO-7807 / BMS, Ono Pharma           
          
            
             
salirasib (KD 032) / Ono Pharma, Sanofi